Teehan Brendan (CIK 1891900) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy PCRX (51,714 shares), Sell PCRX (5,182 shares), Buy PCRX (402 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Chief Commercial Officer | Buy | 51,714 | $0 |
| 2026-02-03 | Pacira BioSciences, Inc. (PCRX) | Chief Commercial Officer | Sell | 5,182 | $106,438 |
| 2026-01-06 | Pacira BioSciences, Inc. (PCRX) | Chief Commercial Officer | Buy | 402 | $4,328 |
Source: SEC Form 4 filings · as of 2026-02-13